Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Neurochem Int. 2010 Dec 22;58(3):321–329. doi: 10.1016/j.neuint.2010.12.004

Figure 3. cis-2-Eicosenoic acid (20:1) and cis-5, 8, 11-Eicosatrienoic acid (20:3) on sAPPα secretion and membrane fluidity in differentiated SH-SY5Y cells.

Figure 3

Western blot analysis of sAPPα shows that treatments of cells with cis-2-Eicosenoic acid (20:1) (A, left) and cis-5, 8, 11-Eicosatrienoic acid (20:3) (B, left) did not affect sAPPα secretion to medium from SH-SY5Y cells. PMA treatment was used as a positive control. cis-2-Eicosenoic acid (20:1) (A, right) and cis-5, 8, 11-Eicosatrienoic acid (20:3) (B, right) did not affect membrane fluidity of cells, as the fluorescent intensity of FCVJ-labeled cells remained unchanged after treatments. Data are expressed as mean ± SD from at least three independent experiments (** p< 0.01 compared with control).